MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
about
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammationBone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects.USPIO-Enhanced MRI Neuroimaging: A Review.Effects of ferumoxytol on quantitative PET measurements in simultaneous PET/MR whole-body imaging: a pilot study in a baboon model.Heat-Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET.Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young AdultsUse of Nanoparticles As Contrast Agents for the Functional and Molecular Imaging of Abdominal Aortic AneurysmParenteral ferumoxytol interaction with magnetic resonance imaging: a case report, review of the literature and advisory warning.Emerging applications for ferumoxytol as a contrast agent in MRI.Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.Status and trends in the development of clinical diagnostic agents.USPIO-related T1 and T2 mapping MRI of cartilage in a rabbit model of blood-induced arthritis: a pilot study.Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.Time-dependent biodistribution, clearance and biocompatibility of magnetic fibrin nanoparticles: an in vivo study.One-Pot Facile Fabrication of Bioavailable Iron Nanoparticles with Good Biocompatibility for Anemia Therapy
P2860
Q26830874-FB8217D7-AD53-424D-97E7-7A26B371CE20Q30677247-D1AC1100-E203-42CA-9CE2-D07D70A8AC6CQ31051172-5BB621E7-0D68-4ACB-B13A-10D76DC87CD2Q35981341-74C5B413-E18C-45A5-9040-83EF99E3DDD6Q36581653-39AA10E2-9EF6-4BEF-BA2A-36E97112D3EAQ36664896-6A1352B5-905D-4FB3-A2B3-75430D094628Q37716747-376C3536-D21E-47BF-8C76-B1AFC743899CQ38113733-BBF09FCC-D57E-4ABA-BCB8-8C9ED15D1C67Q38224182-1B65FC2F-9CF0-418D-A941-D1050672A6E9Q38981471-B38B75FD-0162-4448-A223-1B75774BC388Q38995734-94F100B3-3CBC-4BEA-85E9-05BBBD76B295Q45871592-2633D24B-E383-47DB-8D53-D043CBF5757CQ46071655-535D7943-9D9A-4D57-B80B-283C9DBEB5F2Q46964311-58BD43CA-5D14-4CCD-9DA0-3CFB61EA4FA7Q47199588-82D0B313-0352-4298-A0CF-D35B8ABE5B28Q47872496-235537AF-3600-4B56-9281-662AA4E1F298Q48215270-03264B27-576D-4AD6-A626-1A340295936DQ50214231-D7F46FAF-5012-4115-AE17-D27DACAD8DD9Q58739985-48118DB6-E7E1-486B-B242-2656373A08B0
P2860
MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
MRI assessment of hepatic iron ...... inistration in healthy adults.
@en
MRI assessment of hepatic iron ...... inistration in healthy adults.
@nl
type
label
MRI assessment of hepatic iron ...... inistration in healthy adults.
@en
MRI assessment of hepatic iron ...... inistration in healthy adults.
@nl
prefLabel
MRI assessment of hepatic iron ...... inistration in healthy adults.
@en
MRI assessment of hepatic iron ...... inistration in healthy adults.
@nl
P2093
P1476
MRI assessment of hepatic iron ...... inistration in healthy adults.
@en
P2093
Andrew B Rosenkrantz
Daniel Kim
David R Stoffel
Ruth P Lim
Vivian S Lee
P304
P356
10.1097/RLI.0B013E31826DC151
P577
2012-12-01T00:00:00Z